Select Page
Shelly Lucas is Senior Product Marketing Manager at IntusCare, where she creates thought leadership and educational content for PACE executives and their parent organizations. Prior to IntusCare, she led marketing and content initiatives at Redox and Forcepoint, helping healthcare organizations navigate digital transformation and data-driven care delivery.

The most financially useful information isn’t always the final number. Sometimes it’s an early indication that the expected outcome is changing.

When a PACE program’s risk adjustment factor (RAF) or revenue comes in lower than expected, the first question is usually “What happened?”

The CEO wants the explanation. Finance starts tracing the answer.

But there’s an equally important question your CFO is probably asking:

When did we first have enough information to know something was changing?

By the time a financial variance appears in a reconciliation report, the opportunity to investigate and act may already be gone. The final number is often the last visible step in a process that started months earlier.

The sweep is the checkpoint, not the starting line

PACE finance teams often refer to the reconciliation point as the sweep: when expected RAF and revenue are reconciled against the results CMS ultimately recognizes and pays. The sweep tells you where the submission landed. It doesn’t tell you when it started to diverge from the outcome you expected.

Was a diagnosis held up in documentation? Was a potential condition not substantiated? Did a submission encounter an issue during processing?

The sweep alone doesn’t tell you.

Finding the cause after the fact means teams must piece together submission logs, TPA reports, and underlying participant charts. Often, this reconstruction takes time the team doesn’t have. Every week spent tracing a variance back to its source is a week closer to the CMS reconciliation or run-out deadline, and once that closes, there’s nothing left to act on.

The signal before the variance

By the time a variance reaches reconciliation, it’s already a financial fact. The outcome may be understood, but it may no longer be changeable.

A trajectory is what come before that. It can show that a submission is taking longer than expected, changing status, or moving through the process differently than anticipated. These signals can indicate that the expected outcome is changing while leadership still has the ability to investigate and respond.

the trajectory behind the variance

The earlier a signal is visible, the more time there is to act before the CMS deadline closes.

Reconciliation can tell you what happened. It can’t tell you whether you saw the signal early enough to do something about it. This distinction turns risk adjustment from a reporting exercise into an operational discipline, managing the work behind the number.

Consider a condition identified during an encounter. Weeks later it is documented and submitted, then moves through TPA review, CMS acceptance, and RA eligibility determination. At each stage, the submission’s status is a trajectory: moving forward, stalling, changing, or resolving. That trajectory is visible well before the sweep, to anyone monitoring it.

In a fixed-revenue model, margin protection depends on recognizing operational signals before the relevant CMS reconciliation or final run-out deadline closes. (This is the core premise behind The Margin Window, IntusCare’s executive guide to protecting net margin in PACE.)

Explaining a revenue variance months after the fact isn’t financial strategy. It’s a post-mortem.

Give your CFO visibility before the sweep

If delayed visibility is the core vulnerability, the goal isn’t a better explanation after the fact. It’s earlier visibility across the entire risk adjustment lifecycle while decisions are still available:

  • Before submission: Surface potential documentation and coding opportunities via pre-encounter preparation (PEP) so clinical teams can evaluate them during participant encounters.
  • During processing: Track conditions through TPA review and CMS adjudication, including status and dwell time at stage, with drill-down into the clinical details behind any submission.
  • At the financial layer: Connect clinical work directly to financial results with analytics that show both RAF trends and initial versus adjusted revenue.
  • Across your organization: Analyze results by program, clinic, provider, IDT, or individual participant to identify where results shifted and quantify the financial impact.

This is why we expanded the IRIS risk adjustment platform. Generally available in November 2026, the new IRIS will give PACE organizations visibility across the full risk adjustment lifecycle, from PEP to CMS pipeline tracking and multi-level financial analytics.

Not every discrepancy can be reversed after CMS has made its determination. But some can. A documentation or coding issue may be identified and corrected. A resubmission may still be filed before a deadline.

With this visibility, reconciliation becomes what it should be: confirmation, not discovery. It stops introducing the revenue story and starts confirming what you already know.

Want to see how IRIS changes things for your seat at the table?

Download the IRIS CEO/ED one-pager

See how you can transform your PACE organization

Schedule a demo with our team to learn more about how IntusCare can optimize your organization, streamline communication, and enable better quality and compliance.